High-high intermediate risk endometrial adenocarcinoma: A subset of early stage endometrial cancer patients who benefit from adjuvant therapy

被引：0
|
作者：
Roane, B. M. [1 ]
Kamal, M. Z. [1 ]
Rushton, T. [1 ]
Barrington, D. A. [1 ]
McGwin, G. [1 ]
Arend, R. C. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2249
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [21] Efficacy of adjuvant pelvic and high dose rate intracavitary radiation in patients with intermediate to high risk endometrial cancer
    Dunphy, EA
    Petereit, DG
    Schink, JC
    Grosen, EA
    Hartenbach, EM
    Buchler, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 295 - 295
  • [22] High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy
    Miao, Jin-Wei
    Deng, Xiao-Hong
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 332 - 339
  • [23] High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy
    Jin-Wei Miao
    Xiao-Hong Deng
    Chinese Journal of Cancer Research, 2012, 24 (04) : 332 - 339
  • [24] TREATMENT OF HIGH INTERMEDIATE RISK ENDOMETRIAL CANCER
    Sharaf, P. H.
    Lutz, M. C.
    Manahan, K. J.
    Geisler, J. P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [25] Outcomes after chemotherapy, radiation or combination therapy for high-intermediate and high-risk early-stage endometrial cancer
    Nieto, V. L.
    Wright, J. D.
    Chen, L.
    Hou, J. Y.
    Tergas, A. I.
    Collado, F. Khoury
    St Clair, C. M.
    Melamed, A.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 206 - 206
  • [26] Cost-Effectiveness of Adjuvant Intravaginal Brachytherapy in High-Intermediate Risk Early Stage Endometrial Carcinoma
    Stahl, J. M.
    Lester-Coll, N. H.
    Bledsoe, T. J.
    An, Y.
    Damast, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E416 - E416
  • [27] Combined modality adjuvant therapy for high-risk endometrial cancer
    Vanderstichele, Adriaan
    Neven, Patrick
    Vergote, Ignace
    LANCET ONCOLOGY, 2016, 17 (08): : 1029 - 1030
  • [28] Adjuvant therapy for early-stage endometrial cancer: A review
    Tangjitgamol, S.
    Manusirivithaya, S.
    Lertbutsayanukul, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (05) : 949 - 956
  • [29] Adjuvant therapy for early endometrial cancer - who benefits the most from a radiation therapy?
    Michalak, Marcin
    Warenczak-Florczak, Zaneta
    Staszewska-Nowak, Agnieszka
    Roszak, Andrzej
    GINEKOLOGIA POLSKA, 2020, 91 (01) : 6 - 12
  • [30] Treatment of early stage intermediate-risk endometrial cancer using MIS and adjuvant radiotherapy
    Song, J.
    Le, T.
    Gaudet, M.
    Ee, C.
    Lupe, K.
    Samant, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S806 - S807
12345